摘要:
The invention relates to the technical fields of biology, pharmacology and medicine and the inventive compositions are suitable for use, for example, in the human and animal health fields. More specifically, the invention relates to the use of a cAMP modulator in the preparation of compositions that are intended for the prevention or treatment of peripheral neuropathies. The invention further relates to tools and kits used to prepare the aforementioned compositions.
摘要:
The invention concerns the use of an antigen containing protein A and in particular of Staphylococcus aureus as non-specific antigen introduced in bacterial serology reactions as positive control of the introduction of the serum to be tested.
摘要:
The invention relates to poly-α2,8-sialic acid (PSA) mimetic peptide able to modulate specifically PSA-dependent NCAM functions in vitro and in vivo, characterized in that it presents a sequence consisting of 5 to 30 amino acid residues, preferably 9 to 15, most preferably about 12 amino acid residues, said sequence comprising a B epitope recognized by an anti-poly-α2,8 sialic acid antibody, and to its application for the treatment of neurodegenerative diseases, brain and spine lesions, age-related learning and memory problems, and cancer.
摘要:
The invention concerns the total sequence of the Tropheryma whippelii bacteria rpoB gene, characterised in that it consists of the nucleotide sequence SEQ ID n° 9, and the nucleotide sequences derived from said sequence specific of the Tropheryma whippelii bacteria and their use as probe and primer.
摘要:
The present invention is directed to peptides comprising the sequence ASNKL (SEQ ID N° 1), inducing attraction of the axonal growth in presence of the semaphorin (Sema3A), L1 and NP-1 proteins and their use for the manufacture of a drug for neuronal/axonal regeneration or for treating neurodegenerative diseases. The present invention also includes a method for identifying a compound able to bind the NP-1, a method for identifying a compound able to revert the repulsory effect of Sema3A on the axonal growth from a suited cell, or methods to screen for molecules capable of blocking Sema3A- induced endocytosis.
摘要翻译:本发明涉及肽,其包含序列ASNKL(SEQ ID N°1),诱导轴突生长的吸引力在信号素(检测Sema3A),L 1和NP-1蛋白及其在制备药物中的用途的存在 神经元/轴突再生或用于治疗神经变性疾病。 因此,本发明包括鉴定能够结合NP-1,一种方法,用于鉴定能够恢复检测Sema3A的repulsory作用,对轴突生长从适合的细胞,或方法来筛选能够分子化合物的化合物的方法 阻断Sema3A-诱导的内吞作用。
摘要:
The present invention concerns a TCTP antagonist, in particular a nucleic acid targeting an m RNA encoding Translationally-Controlled Tumor Protein (TCTP), wherein said nucleic acid is capable of reducing the amount of TCTP in cells, for use in the treatment or prevention of hormone-independent cancer or chemo-resistant cancer, such as an androgen-independent prostate cancer.
摘要:
The present invention relates to a neutralizing monoclonal antibody against extracellular HIV-1 trans-activator of transcription protein (Tat), useful as a therapeutic tool or for monitoring the quantity of Tat protein in a sample of a patient infected with a HIV-1.
摘要:
The invention relates to a device for characterising surfaces, characterised in that said device includes: a so-called imaging capillary (C 1 ) for guiding near- or medium-infrared, visible, ultraviolet or X-ray electromagnetic radiation from or towards a surface (SE) to be characterised, said capillary having one so-called front end (EA C1 ), pointing towards said surface and having an opening having a micrometric or sub-micrometric diameter; and a micromechanical oscillator (DP) for inducing an oscillatory motion of said capillary relative to said surface. The invention further relates to the use of such a device for simultaneously acquiring topographic information and spatially resolved spectroscopic information on a surface to be characterised.
摘要:
The present invention relates to peptides biomarkers that are specifically recognized by autoantibodies present in the sera of patients with Rheumatoid Arthritis (RA). More specifically, the invention provides epitopes of PAD4, of BRAF, and of calpastatin as well as methods and kits for using these sequences for the diagnosis of RA, in particular for the diagnosis of RA in CCP-negative subjects.